Background： The purpose of this study is to evaluate the efficiency and safety of sodium aescinate injection for
Introduction
normal appearance, which is beneficial to the early recovery and long-term adaptability of children (Wei et al., 2013; Wei et al., 2014c; Wei et al., 2015) . Flap is the most common and effective method in repairing orthopedic deformities and tissue defect. Yet, the ischemia-reperfusion injury often occurs after flap transplant. This can cause partial or total flap necrosis, and seriously affects the surgical outcome (Harder et al., 2008) . Therefore, during the postoperative period, the effective medicine for preventing the occurrence of complications, and promoting flap survival should be given priority and be taken seriously.
Sodium aescinate is extracted from Borneo sub-dried seeds, which is a natural plant. It has a significant effect on anti-inflammatory, anti-exudative and reducing swelling (Matsuda et al., 1997) . Sodium aescine restores normal capillary permeability, increases venous tension, and improves microcirculation. Sodium aescine also has a strong affinity for scavenging free radicals. It has a phenolic hydroxy in its molecular structure, which explains why it attracts scavenging oxygen free radicals. Sodium aescine was originally prescribed for treating cerebral edema with satisfactory results (Mingrino et al., 1978; Rivano et al., 1969) . Presently, it has been widely applied for the treating a wide There are scant reports regarding sodium aescine in treating children's diseases. The purpose of this study is to
Intervention
The children with tissue defects in their hands or feet were prescribed conventional therapy. Following flap transplantation, homeostasis and analgesia, anti-infection, nutritional support, maintaining water and electrolyte balance treatment were measured. The treatment group was given an additional sodium aescine injection (Shandong Luye Pharmaceutical Co., Ltd., Shandong, China) one day following transplantation (within 24 hr), dosage of sodium aescine injected according to body weight being 0.2 mg / kg, which dissolved in 250ml 0.9% sodium chloride injection.
Maximum daily dose did not exceed 20mg. This continued once per day, 7 days for a full course of treatment.
Variable assessed
At the outset of treatment (within 24 hours) and at 1, 3, 7-days following treatment, C-reactive protein (CRP) and malondialdehyde (MDA) in venous blood were tested. Seven days after treatment, cumulative wound drainage, the swelling of flap and adverse reactions were recorded. One month after treatment, two-point discrimination of flap was recorded during the follow-up. CRP was tested by automatic biochemical analyzer. MDA was determined by thiobarbituric method. Cumulative wound drainage (7 days) included direct wound drainage volume and the amount of fluid intake gauze, the amount of fluid intake gauze bases on area or volume of infiltration.
Two-point discrimination test
All child patients had the purpose and methodology explained to them before testing obtaining and getting their cooperation. During testing, the examiner fixed the patient's limbs and instructed them to close their eyes. While the two needle detectors were descending, the patient was required to indicate when one or two points were felt-quickly.
As the distance between these two detectors decreased, patient was required to state when the two points could not be properly distinguished. Replying correctly more than seven of ten times test was accepted as the correct resolution, the minimum distance at this test is the two-point discrimination detection value (Zhang et al., 2005).
Swelling criteria
With reference to swelling (Liao et al., 2009 ), 0 degree of swelling is when the skin of flap has no swelling, striae of skin exists and elasticity of skin is normal. I degree of swelling is when there is mild swelling of flap compared to normal skin, but there are still sticks and swelling center height ≤ 0.5 cm compared with contralateral normal limb. II degree of swelling is when skin tension increases, striae of skin disappears, but no blisters and swelling center height is in 0.5 to 1cm compared with contralateral normal limb. III degree of swelling is when skin of flap has significant swelling, tension blisters, swelling center height ≥ l cm compared with contralateral normal limb.
Safety evaluation
All patients were involved with safety. Adverse effects were recorded and included dizziness, palpitation, nausea, diarrhea and skin allergies. Other indicators were tested before and after treatment-primarily liver function, kidney function, electrolytes, urine, stool routine and others.
Statistical analysis
Statistical software SPSS17.0 (SPSS software Inc., USA) was used to analyze data. Measurement data was presented as (mean ± standard deviation). T test was used for two groups. The x 2 test was used to analyze numeration data. The Mann-Whitney test was used for non-parametric. P<0.05 was regarded as denoting statistically significant difference.
Results

Comparison of basic characteristics
All child patients completed this study. There was no statistically significant difference (P>0.05) between the two groups in terms of sex (Male/Female), age, trauma site (Hand/Foot) and location(Left/Right). Seven days after treatment, the drainage volume of wound and swelling of flap in the treatment group was better than those in the control group and statistical differences were significant (P<0.05). One month after treatment, two-point discrimination of flap in treatment group was better than that in the control group, this difference being statistically significant (P<0.05)
as provided in Table 1 . 
Comparison of CRP
At the outset of treatment (0-d), there was no statistically significant difference between the two groups in term of CRP (t 0 =0.997, P>0.05). One day following treatment, the concentrations of CRP in both groups rose to a peak.
Likewise the CRP declined between 3 to 7-days following treatment, Concentrations of CRP in the treatment group were again lower than those in the control group (t 1 =3.272, t 3 =8.597, t 7 =8.003, P<0.05). As shown in Figure 1 . 
Comparison of MDA
At the beginning of treatment (0-d), there was no statistically significant difference between the two groups in term of MDA (t 0 =0.112, P>0.05). One day following treatment, the concentrations of MDA in two groups rose to their peak and later the MDA declined between 3 to 7-days following treatment. The concentrations of MDA in treatment group were lower than those in control group (t 1 =9.569, t 3 =10.046, t 7 =7.420, P<0.05). As shown in Figure 2 . 
Safety Evaluation
There were no adverse reactions such as dizziness, palpitation, nausea, diarrhea and skin allergies in either group.
There was no liver malfunctioning, kidney failure or electrolyte imbalance and abnormal urine and stool routine. One child patient in the treatment group had local irritation pain while the intravenous medicine was dripping. However, after slowing the injection rate, these symptoms disappeared. Intravenous injection rate should be 15 to 30 drops/min, and the initial infusion rate should be slightly slower. There was no statistically significant difference between these two groups in terms of the safety (P>0.05).
Discussion
Soft tissue defects in children's hands or feet were oftentimes accompanied by damage to the tendon and/or bones.
If these injuries are not handled properly, it will affect the development and function of the hands and feet. In this study, drainage of wound and swelling of flap in treatment group were better than those in control group and these differences were statistically significant (P<0.05).Sodium aescinate's ability as being anti-leakage and suppressing swelling. A Two-point discrimination test for a treatment group having better results than the control group ca\n be interpreted as sodium aescinate removing excess oxygen free radicals. This reduces the damage caused by inflammation factors and oxygen free radicals and therein promoted neurological recovery of skin flap and the swelling of flap resulting in faster recovery.
Generally, sodium aescinate is prudently dispensed to children. Recently however, it has been generally recommended for treating children related diseases. The safety of treatment group was parallel to that of the control group and sodium aescinate was dispensed cautiously to children with security. When this medicine is prescribed to children, the rate of injection must be controlled and the dosage should be adjusted according to the child's weight and likewise avoiding the medicine being injected into the subcutaneous.
Conclusion
Sodium aescinate can improve the concentrations of both CRP and MDA in children's venous blood, reducing wound drainage, and promoting early sensory recovery of the flap. It has an effective and safe application for treating children with swelling in their hands or feet.
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